624 Targeting Type I arginine methyltransferases promotes T cell mediated antitumor immune responses

• Guangchun Han,
• Linghua Wang,
• Patrick Hwu,
• Weiyi Peng,
• Chunyu Xu,
• Shane O’Brien,
• Yunfei Wang,
• Jiakai Hou,
• Leilei Shi,
• Leila Williams,
• Andrew Fedoriw,
• Kimberly Smitheman,
• Christian Sherk,
• Satyajit Rajapurkar,
• Jenny Laraio,
• Qin Feng,
• Mark Bedford,
• Olena Barbash,
• Ryan Kruger,
• Helai Mohammad

Affiliations

Guangchun Han

1 Genomic Medicine, UT MDACC, Houston, Texas, USA

Linghua Wang

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Patrick Hwu

Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Weiyi Peng

Aff2 grid.240145.60000000122914776Melanoma Medical OncologyUniversity of Texas MD Anderson Cancer Center Houston TX USA

Chunyu Xu

Aff2 grid.240145.60000000122914776Melanoma Medical OncologyUniversity of Texas MD Anderson Cancer Center Houston TX USA

Shane O’Brien

1School of Health and Human Performance, Dublin City University, Dublin, Ireland

Yunfei Wang

Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China

Jiakai Hou

Department of Biology and Biochemistry, University of Houston, Houston, Texas, USA

Leilei Shi

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Leila Williams

KSQ Therapeutics, Cambridge, MA, USA

Andrew Fedoriw

2GlaxoSmithKline, Collegeville, USA

Kimberly Smitheman

2GlaxoSmithKline, Collegeville, USA

Christian Sherk

2GlaxoSmithKline, Collegeville, USA

Satyajit Rajapurkar

2GlaxoSmithKline, Collegeville, USA

Jenny Laraio

2GlaxoSmithKline, Collegeville, USA

Qin Feng

4University of Houston, Houston, TX, USA

Mark Bedford

1MD Anderson Cancer Center, Houston, TX, USA

Olena Barbash

2GlaxoSmithKline, Collegeville, USA

Ryan Kruger

2GlaxoSmithKline, Collegeville, USA

Helai Mohammad

2GlaxoSmithKline, Collegeville, USA